tiprankstipranks
Assertio Therapeutics (ASRT)
:ASRT
US Market

Assertio Therapeutics (ASRT) Financial Statements

Compare
1,114 Followers

Assertio Therapeutics Financial Overview

Assertio Therapeutics's market cap is currently $69.18M. The company's EPS TTM is $-0.226; its P/E ratio is ―; Assertio Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 124.96M$ 152.07M$ 156.23M$ 111.01M$ 106.28M
Gross Profit$ 85.73M$ 125.05M$ 137.49M$ 95.18M$ 86.40M
Operating Income$ -24.48M$ -243.54M$ 57.81M$ 9.42M$ -46.92M
EBITDA$ -24.48M$ -222.45M$ 72.53M$ 38.78M$ -3.20M
Net Income$ -21.48M$ -331.94M$ 109.63M$ -1.28M$ -28.14M
Balance Sheet
Cash & Short-Term Investments$ 100.05M$ 73.44M$ 64.94M$ 36.81M$ 20.79M
Total Assets$ 284.73M$ 286.42M$ 413.91M$ 326.55M$ 303.27M
Total Debt$ 38.81M$ 40.91M$ 66.87M$ 73.49M$ 84.10M
Net Debt$ -11.78M$ -32.53M$ 1.93M$ 36.68M$ 63.32M
Total Liabilities$ 163.65M$ 148.42M$ 188.19M$ 224.13M$ 247.76M
Stockholders' Equity$ 121.08M$ 138.00M$ 225.72M$ 102.41M$ 55.51M
Cash Flow
Free Cash Flow$ 26.41M$ 48.98M$ 78.32M$ 5.47M$ -65.58M
Operating Cash Flow$ 26.41M$ 49.60M$ 78.60M$ 5.52M$ -65.57M
Investing Cash Flow$ -48.91M$ 3.10M$ -42.67M$ -18.52M$ 512.80M
Financing Cash Flow$ -350.00K$ -44.20M$ -7.79M$ 29.03M$ -468.55M
Currency in USD

Assertio Therapeutics Earnings and Revenue History

Assertio Therapeutics Debt to Assets

Assertio Therapeutics Cash Flow

Assertio Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis